Review
doi: 10.1007/BF01059734.
A review of the applications of physiologically based pharmacokinetic modeling
Affiliations
- PMID: 20218010
- DOI: 10.1007/BF01059734
Item in Clipboard
Review
A review of the applications of physiologically based pharmacokinetic modeling
J Pharmacokinet Biopharm.
1979 Apr.
Abstract
The physiological pharmacokinetic approach to the modeling of drug distribution is reviewed. These models allow extrapolation outside the range of data with some confidence if the dominant mechanisms of transport are sufficiently well understood. In addition, it is possible to extrapolate to other species. Compartments correspond to anatomical spaces so that biochemical interactions (including drug effect or pharmacodynamics) can be incorporated in the model. The articles summarized in this review are limited to models dealing with drug application.
Similar articles
-
Physiologically based pharmacokinetics (PBPK).Drug Metab Rev. 2009;41(3):391-407. doi: 10.1080/10837450902891360. Drug Metab Rev. 2009. PMID: 19601719 Review.
-
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.AAPS J. 2017 Jan;19(1):26-42. doi: 10.1208/s12248-016-0010-3. Epub 2016 Nov 10. AAPS J. 2017. PMID: 27834047 Review.
-
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.Curr Opin Drug Discov Devel. 2009 Jul;12(4):509-18. Curr Opin Drug Discov Devel. 2009. PMID: 19562647 Review.
-
Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.Expert Opin Drug Metab Toxicol. 2007 Dec;3(6):865-78. doi: 10.1517/17425255.3.6.865. Expert Opin Drug Metab Toxicol. 2007. PMID: 18028030 Review.
-
Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.Curr Drug Metab. 2018;19(12):972-978. doi: 10.2174/1389200219666180702104034. Curr Drug Metab. 2018. PMID: 29962340 Review.
Cited by
-
The use of mass balance principles to describe regional drug distribution and elimination.J Pharmacokinet Biopharm. 1988 Feb;16(1):13-29. doi: 10.1007/BF01061860. J Pharmacokinet Biopharm. 1988. PMID: 3373417
-
Construction of a whole body blood flow model for use in positron emission tomography imaging with [15O]water.J Pharmacokinet Biopharm. 1997 Oct;25(5):539-68. doi: 10.1023/a:1025759213617. J Pharmacokinet Biopharm. 1997. PMID: 9679222
-
ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081. Toxicol Sci. 2023. PMID: 37584694 Free PMC article.
-
Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.J Pharmacokinet Biopharm. 1983 Dec;11(6):577-93. doi: 10.1007/BF01059058. J Pharmacokinet Biopharm. 1983. PMID: 6678311
-
Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data.J Pharmacokinet Biopharm. 1982 Dec;10(6):649-61. doi: 10.1007/BF01062546. J Pharmacokinet Biopharm. 1982. PMID: 7182460